FBRX vs T · $360.2M cap vs P/E 7.4, rev $125.65B
Forte Biosciences Inc (FBRX) versus AT&T Inc. (T) — a side-by-side from cached financials, not a winner call.
Forte Biosciences Inc (FBRX) is a biotechnology company listed on NASDAQ.
AT&T Inc. (T) is a telecom services company listed on NYSE. It is led by John Stankey.
FBRX does not have a complete income-statement cache yet.
Latest reported T revenue for 2025-12-31 was $125.65B. Net income was $21.95B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. T currently screens at market cap $155.92B and trailing P/E 7.4.
FBRX currently screens at market cap $360.2M. T currently screens at market cap $155.92B and trailing P/E 7.4.
Not investment advice. Open the FBRX and T stock pages for the full models.
Not investment advice.